Skip to main content
. 2017 Aug 29;7:9815. doi: 10.1038/s41598-017-10168-6

Figure 3.

Figure 3

Decreased inflammation, inflammatory mediator production and apoptosis with 6-ECDCA pretreatment. (A and B) Representative images of immunostaining for (A) CD4 and (B) TNFα in renal sections from (a) sham, (b) I/R and (c) I/R + ECDCA groups (scale bar 50 μm). Note the tubulointerstitial localization of CD4+ and TNFa+ inflammatory cells. (C) Levels of mRNA for Tnfα, Il6 and Mcp1 in kidney tissue. n = 6 mice/group. (D and E) Blood levels of (D) TNFα and (E) MCP1. n = 6 mice/group. (F) Representative images of TUNEL staining on renal sections from (a) sham, (b) I/R and (c) I/R + ECDCA groups (scale bar 50 μm). Arrows indicate apoptotic bodies. (G) Quantitative analysis of positive TUNEL stained cells per high power field. n = 6 mice/group. (H) Levels of Bax, Caspase3 and Bcl2 mRNA in kidney tissue. n = 6 mice/group. Data are means ± SEM, one-way ANOVA with Bonferroni’s test. *p < 0.05. (I) Western blot analysis of ICAM and cleaved-caspase 3 protein levels in kidney samples of sham, I/R and I/R + ECDCA mice.